Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CTSO - Cytosorbents Corp

Previous close
1.05
-0.070   -6.667%

Share volume: 454,404
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing : -0.22%

PREVIOUS CLOSE
CHG
CHG%
$1.12
0.11
0.12%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 8%
Dept financing 26%
Liquidity 23%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
11.98%
1 Month
15.42%
3 Months
-4.55%
6 Months
-1.87%
1 Year
3.96%
2 Year
-53.74%
Key data
Stock price
$1.05
P/E Ratio 
0.00
DAY RANGE
$0.92 - $1.14
EPS 
$0.00
52 WEEK RANGE
$0.75 - $1.59
52 WEEK CHANGE
$3.96
MARKET CAP 
81.644 M
YIELD 
N/A
SHARES OUTSTANDING 
54.430 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.10
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$462,864
AVERAGE 30 VOLUME 
$595,433
Company detail
CEO: Phillip P. Chan
Region: US
Website: cytosorbents.com
Employees: 220
IPO year: 2008
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices. Its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals.

Recent news